Endocrine and metabolic issues in the management of the chronically critically ill patient

Critical Care Clinics

Volumn 18, Issue 3, 2002, Pages 619-641

  Mechanick, Jeffrey I ^a   Brett, Elise M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ASPART; CALCITRIOL; CATECHOLAMINE; CORTICOTROPIN; GLARGINE; GONADORELIN; GROWTH HORMONE RELEASING FACTOR; INSULIN; INSULIN GLARGINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; LEVOTHYROXINE; LUTEINIZING HORMONE; METFORMIN; PAMIDRONIC ACID; PRASTERONE SULFATE; PROPRANOLOL; PROPYLTHIOURACIL; SOMATOMEDIN C; TESTOSTERONE; TETRACOSACTIDE; THIAMAZOLE; THYROTROPIN; UNCLASSIFIED DRUG;

ADRENAL DISEASE; BODY COMPOSITION; CHRONIC DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; CRITICAL ILLNESS; DIABETES MELLITUS; ENDOCRINE SYSTEM; ENERGY METABOLISM; HOMEOSTASIS; HUMAN; HYPERTHYROIDISM; HYPOGONADISM; HYPOTHYROIDISM; IMMOBILIZATION; KWASHIORKOR; METABOLIC BONE DISEASE; METABOLIC CAPACITY; PRIORITY JOURNAL; REVIEW;

ADRENAL GLAND DISEASES; BONE DISEASES, METABOLIC; CHRONIC DISEASE; CRITICAL ILLNESS; DIABETES MELLITUS; ENDOCRINE SYSTEM; HUMANS; HYPERCALCEMIA; METABOLIC DISEASES; THYROID DISEASES;

EID: 0036314267     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(02)00005-2     Document Type: Review

References (149)

1. Editorial: A healthy body in a healthy mind - And vice versa - The damaging power of "uncontrollable" stress
2. On the neuroendocrinology of prolonged critical illness: Effect of continuous thyrotropin-releasing hormone infusion and its combination with growth hormone-secretagogues
3. Effects of lactate on glucose metabolism in healthy subjects and in severely injured hyperglycemic patients
4. Hyperglycemia after trauma increase with age
5. Correlation between measured energy expenditure and clinically obtained variables in trauma and sepsis patients
6. Perioperative total parenteral nutrition in surgical patients
7. Predictors of total parenteral nutrition-induced lipogenesis
8. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabets mellitus: DIGAMI Study Group
9. Complications of coronary artery surgery in diabetic patients
10. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures
11. Intensive insuline therapy in the critically ill patient
12. Effects of an intervention by a diabetes team in hospitalized patients with diabetes
13. Contraindications to metformin therapy in patients with NIDDM
14. Bone turnover markers and bone density across the menopausal transition
15. Markers of bone resorption in patients treated with pamidronate
16. Bone hyperresorption is prevalent in chronically critically ill patients
17. Parathyroid hormone suppression in spinal cord injury patients is associated with the degree of neurologic impairment and not the level of injury
18. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: A prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone
19. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure
20. Prevention of bone loss after heart transplantation with antiresorptive therapy: A pilot study
21. Effect of calcitriol on bone loss after cardiac or lung transplantation
22. Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation
23. Polyarticular heterotopic ossification complicating critical illness
24. Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia
25. Hypercalcemia and sarcoidosis - Another piece of the puzzle falls into place
26. Correlation between 25-hydroxyvitamin D3 1-hydroxlase gene expression in alveolar macrophages and the activity of sarcoidosis
27. Clinical impact of bone and calcium metaoblism changes in sarcoidosis
28. Biochemical response to treatment of bone hyperresorption in chronically critical ill patients
29. Aluminum in parenteral nutrition solution - Sources and possible alternatives
30. Hypocalcemia induced during major and minor abdominal surgery in humans
31. Hypocalcemic sundromes
32. Hypophosphatemia as a cause of failed weaning: The importance of metabolic factors
33. Treatment of hypophosphatemia in patients receiving specialized nutrition support using a graduated dosing scheme: Results from a prospective clinical trial
34. Intravenous phosphate repletion regimens for criticlaly ill patients with moderate hypophsophatemia
35. Magnesium deficiency in a medical ICU population
36. Functional magnesium deficiency in critically ill patients identified using a magnesium loading test
37. Cardiovascular actions of magnesium
38. High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease
39. Abnormalities in thyroid function tests in patients admitted to a medical service
40. Frequency of euthyroid sick syndrome as assessed by free thyroxine index and a direct free thyroxine assay: A limitation of FT4 assays
41. Simultaneous measurement of free thyroxine and free 3,5,3′;-triiodothyronine in undiluted serum by direct equilibrium dialysis/radioimmunoassay: Evidence that free triiodothyronine and free thyroxine are normal in many patients with the low triiodothyronine syndrome
42. Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3′;-triiodothyronine in sera of patients with non-thyroidal illness
43. In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroid illnesses
44. Slow thyroxine binding globulin in the pathogenesis of increased dialyzable fraction of thyroxine in nonthyroidal illness
45. Suppression of thyrotropin-releasing hormone gene expression by interleukin-1-beta in the rat: Implications for nonthyroidal illness
46. Hypothyroxinemia in critically ill patients as a predictor of high mortality
47. Inhibition of phagocytosis and chemiluminescence in human leukocytes by a lipid soluble factor in normal tissue
48. Endocrine profiles for outcome prediction from the intensive care unit
49. Relationship of altered thyroid hormone indices to survival in nonthyroidal illnesses
50. Do thyroid function tests indipendently predict survival in the critically ill?
51. Thyrotropin concentration predicts outcome in critical illness
52. Effects of acute and chronic interleukin-6 administration on the thyroid hormone metabolism in humans
53. Tumor necrosis factor: A putative mediator of the sick euthyroid syndrome in man
54. Relationship of admission thyroid function tests to outcome in critical illness
55. Thyrotropin and prolactin release in prolonged critical illness: Dynamics of spontaneous secretion and effects of growth hormone secretagogues
56. Hypothalamic-pituitary axis dysfunction in critically ill patients with a low free thyroxine index
57. The relationship between serum triiodothyronine and thyrotropin during systemic illness
58. Thyroxine therapy in patients with severe nonthryoidal illnesses and low serum thyroxine concentration
59. Enteral feeding: Drug/nutrient interaction
60. Medical management of hyperthyroidism: Theoretical and practical aspects
61. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
62. Corticosteroid therapy in severe illness
63. Perioperative glucocorticoid coverage: A reassessment 42 years after emergence of a problem
64. Adrenal insufficiency in critically ill patients
65. A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency
66. Specificity of urinary excretion of cross-linked Ntelopeptides of type-1 collagen as markers of bone turnover in humans
67. Relative eosinophilia and functional adrenal insufficiency in critically ill patients
68. Tumor necrosis factor-alpha is a potent ACTH secretagogue: Comparison to interleukin-1 beta
69. Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors
70. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: Possible role of endothelin and atrial natriuretic hormone
71. Stress update: Adaptation of the hypothalamic-pituitary-adrenal axis to chronic stress
72. A comparison of the adrenocortical response during septic shock and complete recovery
73. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
74. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: Altered response to corticotropin-releasing hormone
75. Hypothalamic-pituitary-adrenal insufficiency
76. Low dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids
77. The role of high- and low-dose corticotropin test in the diagnosis of secondary adrenal insufficiency
78. Dehydro epiandrosterone, dehydroepiandrosterone-sulfate, and cortisol concentrations in intensive care unit patients
79. Evidence for adrenocortical adaptation to severe illness
80. Dehydroepiandrosterone enhances IL-2 production and cytotoxic effector function of human T-cells
81. Dehydroepiandrosterone sulphate in critical illness: Effect of dopamine
82. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells
83. Hyperreninemic hypoaldosteronism in the critically ill: A new entity
84. When is cortisol a mineralcorticoid
85. Hypotension and adrenal insufficiency
86. Adrenal failure in the critically ill
87. Catecholamine dependency in a polytrauma patient: Relative adrenal insufficiency?
88. A controlled clinical trial of high dose methylprednisolone in the treatment of severe sepsis and septic shock
89. Effect of high dose glucocorticoid therapy on mortality in patients with clinical sepsis
90. Reversal of late septic shock with supraphysiologic doses of hydrocortisone
91. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study
92. Adrenal insufficiency in high-risk surgical ICU patients
93. Mcchanism of vasopressin action in the renal collecting duct
94. Vasopressing increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane
95. Atrial natriuretic factor inhibits vasopressin stimulated osmotic water permeability in rat inner medullary collecting duct
96. Plasma vasopressin and atrial natriuretic hormone levels in hypopituitarism with and without hydrocortisone treatments: Responses to an acute water load
97. Diuretic induced hyponatremia
98. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple organ defects
99. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage
100. Role of brain ouabain-like compound in central nervous systemmediated natriuresis in rats
101. Neural control of renal function in health and disease
102. Hyponatremia
103. Changes in renal function in primary hypothyroidism
104. Osmoregulation of plasma vasopressin in myxedema
105. Acute suppression of plasma vasopressin and thirst after drinking in hypernatremic man
106. Neurogenic disorders of osmoregulation
107. Biosynthesis of vasopressin in vitro and ultrastructure of a bronchogenic cancer
108. Hyponatremia
109. Hyponatremia
110. Hyponatremia responsive to fludrocortisone acetate in elderly patients after head injury
111. Improved effect of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage
112. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone
113. Renal failure associated with demeclocycline in cirrhosis
114. Rapid correction of severe hyponatremia with intravenous hypertonic saline solution
115. Protein oxidation and myelinolysis occur in brain following rapid correction of hyponatremia
116. Neurologic complications following liver transplantation
117. Changing concepts in treatment of severe symptomatic hyponatremia
118. Management of severe hyponatremia: Rapid or slow correction
119. Severe symptomatic hyponatremia: Treatment and outcome
120. Tube feeding syndrome revisited
121. Fluid and electrolytes
122. Circulating immunoreactive inhibin and testosterone levels in men with critical illness
123. Reproduction axis suppression in acute illness is related to disease severity
124. Amplitude suppression of the pulsatile mode of the immunoradiometric LH release in fasting-induced hypoandrogenemia in normal men
125. Suppression of plasma testosterone levels and psychological stress: A longitudinal study of young men in officer candidate school
126. Diet, absorption and hormone studies in relation to body weight in obstructive airways disease
127. Effect of surgical stress on pituitary-testicular function
128. Effect of acute myocardial infarction on pituitary testicular function
129. Pituitary-testicular axis dysfunction in burned men
130. Serum androgens in intensive-care patients: Correlation with clinical findings
131. Transient hypogonadotropic hypogonadism caused by critical illness
132. Luteinizing hormone secretion and hypoandrogenemia in critically ill men: Effect of dopamine
133. Interleukin-2 is a potent inhibitor of Leydig cell steroidogenesis
134. Both hyper- and hypogonadotrophic hypogonadism occur transiently in acute illness: Bio- and immunoreactive gonadotropins
135. Abnormalities of the hypothalamic-pituitary-gonadal axis after head injury
136. Hypotestosteronemia in chronically critically ill men
137. Hypothalamic hypogonadism following major head injury
138. Endocrine evaluation of testicular function
139. The use and misuse of androgens
140. Nutrition and the respiratory muscles
141. Muscle dusfunction in malnourished patients
142. Nutrition and wound healing
143. Testosterone replacement in hypogonadal men: Effects on obstructive sleep apnoea, respiratory drive and sleep
144. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men: A clinical research center study
145. Trophic factors in aging: Should older people receive hormonal replacement therapy?
146. Testosterone replacement therapy improves mood in hypogonadal men: A clinical research center study
147. Testosterone and the aging male
148. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: Results of a Department of Veterans Affairs Cooperative Study
149. Suppression of gonadotropin secretion in the hospitalized postmenopausal female as an effect of acute illness